Filing Details
- Accession Number:
- 0001213900-21-030054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-28 18:49:46
- Reporting Period:
- 2021-05-25
- Accepted Time:
- 2021-05-28 18:49:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1726711 | Aditx Therapeutics Inc. | ADTX | Pharmaceutical Preparations (2834) | 823204328 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1816754 | Shahrokh Shabahang | C/O Aditx Therapeutics, Inc. 2569 Wyandotte St., Suite 101 Mountain View CA 94043 | Chief Innovation Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-25 | 279 | $2.40 | 1,015,285 | No | 4 | P | Indirect | By son |
| Common Stock | Acquisiton | 2021-05-25 | 138 | $2.38 | 1,015,423 | No | 4 | P | Indirect | By son |
| Common Stock | Acquisiton | 2021-05-27 | 185 | $2.70 | 1,015,608 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By son |
| No | 4 | P | Indirect | By son |
| No | 4 | P | Direct |
Footnotes
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- Fractional amounts have been rounded to the nearest whole number.
Billionaire Hedge Funds
